+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized Forecasting/Analysis, and Executive and Consultant Guides 2021-2025

  • ID: 5189753
  • Report
  • November 2020
  • Region: Global
  • 417 Pages
  • Howe Sound Research
1 of 4
Cancer Gene Profiling Changes Cancer Diagnosis and Treatment. New Science Creating New Market Opportunities with Regularity. Market Affected by COVID-19 Pandemic.

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bioarray Genetics
  • Chronix Biomedical
  • Foundation Medicine
  • Invitae Corporation
  • Perkin Elmer
  • MORE

Cancer Gene Panels and Genomic Profiling are quickly changing the diagnosis and treatment of cancers. The market is moving out of a specialized niche and going mainstream as Oncologists begin routinely using information on the hundreds of genes related to cancer. The market is exploding as physicians use all the information they can get in the battle against cancer. And there is a lot of information to be had. But the COVID-19 Pandemic has impacted the market. Find out how in this thorough report.

Comprehensive panels, genomic profiling, high-risk breast cancer panels. Learn all about how players are jockeying for position in a market that is being created from scratch. And some players are already taking the lead. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing. And the science is developing at the same time creating new opportunities with regularity. And the cost of sequencing continues to fall.

This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help understand test pricing in detail. Forecast demand for new testing regimes or technologies. Make research investment decisions. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bioarray Genetics
  • Chronix Biomedical
  • Foundation Medicine
  • Invitae Corporation
  • Perkin Elmer
  • MORE

Cancer Panel Market - Strategic Situation Analysis & COVID Update

  • Guide for Executives, Marketing, Sales and Business Development Staff
  • Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition
1.1 What are Cancer Gene Panels and Profiling?
1.2 The Sequencing Revolution
1.3 Market Definition
1.3.1 Revenue Market Size
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 A Spending Perspective on Clinical Laboratory Testing
1.5.1 An Historical Look at Clinical Testing

2. Market Overview
2.1 Players in a Dynamic Market
2.1.1 Academic Research Lab
2.1.2 Diagnostic Test Developer
2.1.3 Instrumentation Supplier
2.1.4 Distributor and Reagent Supplier
2.1.5 Independent Testing Lab
2.1.6 Public National/regional lab
2.1.7 Hospital lab
2.1.8 Physician Office Labs
2.1.9 Audit Body
2.1.10 Certification Body
2.2 Oncogenomics
2.2.1 Carcinogenesis
2.2.2 Chromosomes, Genes and Epigenetics
2.2.2.1 Chromosomes
2.2.2.2 Genes
2.2.2.3 Epigenetics
2.2.3 Cancer Genes
2.2.4 Germline vs Somatic
2.2.5 Gene Panels, Single Gene Assays and Multiplexing
2.2.6 Genomic Profiling
2.2.7 The Comprehensive Assay
2.2.8 Changing Clinical Role
2.2.9 The Cancer Screening Market Opportunity
2.3 Cancer Management vs. Diagnosis
2.3.1 The Role of Risk Assessment
2.3.2 Diagnosis
2.3.3 Managing
2.3.4 Monitoring
2.4 Phases of Adoption - Looking into The Future
2.5 Structure of Industry Plays a Part
2.5.1 Hospital Testing Share
2.5.2 Economies of Scale
2.5.2.1 Hospital vs. Central Lab
2.5.3 Physician Office Lab’s
2.5.4 Physician’s and POCT

3. Market Trends
3.1 Factors Driving Growth
3.1.1 Level of Care
3.1.2 Companion Dx
3.1.3 Immuno-oncology
3.1.4 Liability
3.1.5 Aging Population
3.2 Factors Limiting Growth
3.2.1 State of knowledge
3.2.2 Genetic Blizzard.
3.2.3 Protocol Resistance
3.2.4 Regulation and coverage
3.3 Instrumentation and Automation
3.3.1 Instruments Key to Market Share
3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.1 Next Generation Sequencing Fuels a Revolution
3.4.2 Single Cell Genomics Changes the Picture
3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.4 CGES Testing, A Brave New World
3.4.5 Biochips/Giant magnetoresistance based assay

4. Cancer Panels & Profiles Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section

  • Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform
  • Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
  • Metastatic Cancer Markers Identified in Clinical WGS Study
  • Stitch Bio Bets on CRISPR Tech
  • Bayer, LifeLabs Launch Free NTRK Genetic Testing Program
  • Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Dx
  • Progress, Challenges in Liquid Biopsy Reimbursement
  • Israeli Startup Curesponse Raises $6M
  • Invitae, ArcherDX Merge to Advance Precision Oncology Offerings
  • MD Anderson Precision Oncology Decision Support to Use Philips' Informatics Solution
  • NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program
  • Germline Results Guides Precision Therapy in Advanced Cancer
  • FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics
  • ArcherDX, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers
  • Labs Reporting Cancer Risk Mutations from Tumor Testing
  • Users Begin Integrating Genomics Data for Clinical Decision Support
  • Fujitsu Improves Efficiency in Cancer Genomic Medicine
  • Thermo Fisher's automated sequencer to offer same-day, pan-cancer test results
  • Universal Genetic Testing for All Breast Cancer Patients
  • Exact Sciences buys Genomic Health
  • Multi-Gene Liquid Biopsy Breast Cancer Panel
  • Thrive to Develop Earlier Detection of Multiple Cancer Types
  • New Gene Panel Identifies High Risk Prostate Cancer
  • Guardant Health Liquid Biopsy Test to be Covered by EviCore
  • Biocept Partnership Offering for Liquid Biopsy Adds Several Key Services
  • Natera Commercializes Tumor Whole Exome Sequencing from Plasma
  • Inivata Completes £39.8M Series B Funding Round
  • Bio-Rad Clinical ddPCR Test, Diagnostic System Get FDA Clearance
  • CellMax, Medigen Biotech Partner in Colorectal Cancer Clinical Trials
  • Biodesix Acquires Integrated Diagnostics
  • Predicine, Kintor Pharmaceuticals Partner on Clinical Trials, CDx

5. Profiles of Key Players

  • Abbott Diagnostics
  • AccuraGen Inc
  • Acuamark Diagnostics
  • Admera Health, LLC
  • Agena Bioscience, Inc
  • Agilent
  • Almac Diagnostics
  • Amoy Diagnostics Co., Ltd.
  • Anchor Dx
  • ANGLE plc
  • ApoCell, Inc.
  • ArcherDx, Inc
  • Asuragen
  • AVIVA Biosciences
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocartis
  • Biocept, Inc
  • Biodesix Inc
  • BioFluidica
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Bioview
  • Blueprint Genetics
  • Bolidics
  • Boreal Genomics
  • Caris Molecular Diagnostics
  • CellMax Life
  • Cepheid (now Danaher)
  • Chronix Biomedical
  • Circulogene
  • Clinical Genomics
  • Cynvenio
  • Cytolumina Technologies Corp
  • CytoTrack
  • Datar Cancer Genetics Limited
  • Diagenode Diagnostics
  • Diagnologix LLC
  • Enzo Life Sciences, Inc
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Exosome Diagnostics
  • Exosome Sciences
  • Fluidigm Corp
  • Fluxion Biosciences
  • Foundation Medicine
  • Freenome
  • Fulgent Genetics
  • GeneFirst Ltd.
  • Genetron Health (Beijing) Co., Ltd
  • Genomic Health
  • GILUPI Nanomedizin
  • Grail, Inc.
  • Guardant Health
  • HansaBiomed
  • HeiScreen
  • Helomics
  • Horizon Discovery 224 iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Invitae Corporation
  • Integrated Diagnostics
  • Janssen Diagnostics
  • Loxo Oncology
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Menarini Silicon Biosystems
  • Millipore Sigma
  • Miltenyi Biotec
  • miR Scientific
  • Molecular MD
  • Myriad Genetics/Myriad RBM
  • NantHealth, Inc.
  • Natera
  • NeoGenomics
  • New Oncology
  • Novogene Bioinformatics Technology Co., Ltd.
  • Oncocyte
  • OncoDNA
  • Oxford Nanopore Technologies
  • Perkin Elmer
  • Personal Genome Diagnostics
  • PrecisionMed
  • Promega
  • Qiagen Gmbh
  • Quidel
  • Rarecells SAS
  • RareCyte
  • Resolution Biosciences, Inc
  • Roche Molecular Diagnostics
  • Screencell
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc
  • SRI International
  • Sysmex Inostics
  • Tempus Labs, Inc
  • Thermo Fisher Scientific Inc.
  • Thrive Earlier Detection
  • Trovagene
  • Volition

6. The Global Market for Cancer Gene Panels and Profiles
6.1 Global Market Overview by Country
6.1.1 Table - Global Market by Country
6.1.2 Chart - Global Market by Country
6.2 Global Market by Cancer Type - Overview
6.2.1 Table - Global Market by Cancer Type
6.2.2 Chart - Global Market by Cancer Type - Base/Final Year Comparison
6.2.3 Chart - Global Market by Cancer Type - Base Year
6.2.4 Chart - Global Market by Cancer Type - Final Year
6.2.5 Chart - Global Market by Cancer Type - Share by Year
6.2.6 Chart - Global Market by Cancer Type - Segment Growth
6.3 Global Market Germline & Somatic - Overview
6.3.1 Table - Global Market Germline & Somatic
6.3.2 Chart - Global Market Germline & Somatic - Base/Final Year Comparison
6.3.3 Chart - Global Market Germline & Somatic - Base Year
6.3.4 Chart - Global Market Germline & Somatic - Final Year
6.3.5 Chart - Global Market Germline & Somatic - Share by Year
6.3.6 Chart - Global Market Germline & Somatic - Segment Growth

7. Global Cancer Gene Panels & Profiles Markets - By Type of Cancer
7.1 Comprehensive Panels & Profiles
7.1.1 Table Comprehensive Testing - by Country
7.1.2 Chart - Comprehensive Testing Growth
7.2 Breast Cancer Gene Testing
7.2.1 Table Breast Cancer Gene Testing - by Country
7.2.2 Chart - Breast Cancer Testing Growth
7.3 Colorectal Cancer Gene Testing
7.3.1 Table Colorectal Cancer Gene Testing - by Country
7.3.2 Chart - Colorectal Cancer Gene Testing Growth
7.4 Gynecological Cancer Gene Testing
7.4.1 Table Gynecological Cancer Gene Testing - by Country
7.4.2 Chart - Gynecological Cancer Gene Testing Growth
7.5 Blood Cancer Gene Testing
7.5.1 Table Blood Cancer Gene Testing - by Country
7.5.2 Chart - Blood Cancer Gene Testing Growth
7.6 Prostate Cancer Gene Testing
7.6.1 Table Prostate Cancer Gene Testing - by Country
7.6.2 Chart - Prostate Cancer Testing Growth
7.7 Lung Cancer Gene Testing
7.7.1 Table Lung Cancer Gene Testing - by Country
7.7.2 Chart - Lung Cancer Gene Testing Growth
7.8 Other Cancer Gene Testing
7.8.1 Table Other Cancer Gene Testing - by Country
7.8.2 Chart - Other Cancer Gene Testing Growth

8. Global Cancer Gene Testing Markets - Germline and Somatic
8.1 Global Market Somatic
8.2.1 Table Somatic - by Country
7.2.2 Chart - Somatic Testing Growth
7.3 Global Market Germline
7.3.1 Table Germline - by Country
7.3.2 Chart - Germline Testing Growth

9. Potential Market Opportunity Sizes
9.1 Potential Cancer Screening by Country: Lung, Breast & Colorectal
9.2 Potential Cancer Screening by Country: Prostate, Other Cancer & All Cancer
9.3 Potential Market Size - Cancer Diagnosis
9.4 Potential Market Size - Therapy Selection

Appendices

  • United States Medicare System: January 2020 Clinical Laboratory Fees Schedule
  • FDA Approved Human Genetic Tests
  • Pharmacogenomic Biomarkers in Drug Labeling

List of Tables
Table 1 Medicare Clinical Lab Expenditures Actual & Forecast 2014 to 2024 ($Billion)
Table 2 Market Players by Type
Table 3 The Base Pairs
Table 4 Five Factors Driving Growth
Table 5 Four Factors Limiting Growth
Table 6 Key Diagnostic Laboratory Technology Trends
Table 7 Next Generation Sequencing Technologies - Speed and Cost
Table 8 Global Cancer Panel Market by Region
Table 9 Global Market by Cancer Type
Table 10 Global Market Germline & Somatic
Table 11 Comprehensive Testing by Country
Table 12 Breast Cancer Gene Testing by Country
Table 13 Colorectal Cancer Gene Testing by Country
Table 14 Gynecological Cancer Testing by Country
Table 15 Blood Cancer Gene Testing by Country
Table 16 Prostate Cancer Gene Testing by Country
Table 17 Lung Cancer Gene Testing by Country
Table 18 Other Cancer Gene Testing by Country
Table 19 Somatic by Country
Table 20 Germline by Country
Table 21 Potential Screening Market: Lung, Breast & Colorectal
Table 22 Potential Screening Market: Prostate, Other & All
Table 23 Potential Cancer Diagnosis Market Size
Table 24 Potential Cancer Management Market Size
Table 25 2020 Laboratory Fee Schedule
Table 26 FDA Approved Human Genetic tests
Table 27 Pharmacogenomic Biomarkers

List of Figures
Figure 1 VistSeq Hereditary Cancer Panel
Figure 2 Medicare Clinical Lab Expenditures 2014 to 2024 ($Million)
Figure 3 The Genomic Progression of Cancer
Figure 4 DNA Strands and Chromosomes
Figure 5 Karyogram of Human Chromosomes
Figure 6 Size of Various Genomes
Figure 7 Germline vs Somatic Mutations
Figure 8 Comparing Genomic Diagnostic and Traditional Testing
Figure 9 Percentage of World Population Over 65
Figure 10 Base Year Country Global Share
Figure 11 Global Market by Cancer - Base vs. Final Year
Figure 12 Cancer Panel Market Base Year
Figure 13 Cancer Panel Market Final Year
Figure 14 Cancer Type Share by Year
Figure 15 Cancer Type Segment Growth
Figure 16 Germline & Somatic - Base vs. Final Year
Figure 17 Germline & Somatic Market Base Year
Figure 18 Germline & Somatic Market Final Year
Figure 19 Germline & Somatic Share by Year
Figure 20 Germline & Somatic Segment Growth
Figure 21 Comprehensive Testing Growth
Figure 22 Breast Cancer Testing Growth
Figure 23 Colorectal Cancer Gene Testing Growth
Figure 24 Gynecological Cancer Testing Growth
Figure 25 Blood Cancer Gene Testing Growth
Figure 26 Prostate Cancer Gene Testing Growth
Figure 27 Lung Cancer Gene Testing Growth
Figure 28 Other Cancer Gene Testing Growth
Figure 29 Somatic Testing Growth
Figure 30 Germline Testing Growth

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • AccuraGen Inc
  • Acuamark Diagnostics
  • Admera Health, LLC
  • Agena Bioscience, Inc
  • Agilent
  • Almac Diagnostics
  • Amoy Diagnostics Co., Ltd.
  • Anchor Dx
  • ANGLE plc
  • ApoCell, Inc.
  • ArcherDx, Inc
  • Asuragen
  • AVIVA Biosciences
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Bioarray Genetics
  • Biocartis
  • Biocept, Inc
  • Biodesix Inc
  • BioFluidica
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bioview
  • Blueprint Genetics
  • Bolidics
  • Boreal Genomics
  • Caris Molecular Diagnostics
  • CellMax Life
  • Cepheid (now Danaher)
  • Chronix Biomedical
  • Circulogene
  • Clinical Genomics
  • Cynvenio
  • Cytolumina Technologies Corp
  • CytoTrack
  • Datar Cancer Genetics Limited
  • Diagenode Diagnostics
  • Diagnologix LLC
  • Enzo Life Sciences, Inc
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Exosome Diagnostics
  • Exosome Sciences
  • Fluidigm Corp
  • Fluxion Biosciences
  • Foundation Medicine
  • Freenome
  • Fulgent Genetics
  • GeneFirst Ltd.
  • Genetron Health (Beijing) Co., Ltd
  • Genomic Health
  • GILUPI Nanomedizin
  • Grail, Inc.
  • Guardant Health
  • HansaBiomed
  • HeiScreen
  • Helomics
  • Horizon Discovery 224 iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Janssen Diagnostics
  • Loxo Oncology
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Menarini Silicon Biosystems
  • Millipore Sigma
  • Miltenyi Biotec
  • miR Scientific
  • Molecular MD
  • Myriad Genetics/Myriad RBM
  • NantHealth, Inc.
  • Natera
  • NeoGenomics
  • New Oncology
  • Novogene Bioinformatics Technology Co., Ltd.
  • Oncocyte
  • OncoDNA
  • Oxford Nanopore Technologies
  • Perkin Elmer
  • Personal Genome Diagnostics
  • PrecisionMed
  • Promega
  • Qiagen Gmbh
  • Quidel
  • Rarecells SAS
  • RareCyte
  • Resolution Biosciences, Inc
  • Roche Molecular Diagnostics
  • Screencell
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc
  • SRI International
  • Sysmex Inostics
  • Tempus Labs, Inc
  • Thermo Fisher Scientific Inc.
  • Thrive Earlier Detection
  • Trovagene
  • Volition
Note: Product cover images may vary from those shown
Adroll
adroll